Enter OTP
Lyon, France
Cost Of Living
Undergraduate Fees International Students
Post Graduate Fees International Students
The below information is required while
completing the university application :
key documents typically required for admission to a Bachelor’s degree (Licence / BUT) at Claude Bernard University Lyon?1:
1. High School Diploma and Official Transcripts
You must provide an official copy of your secondary school certificate (e.g., Baccalauréat, IB, A?Levels, or equivalent) and full transcripts. For international applicants, documents should be translated into French or English and officially certified. These confirm you meet the academic entry threshold to start a Licence program.
2. Language Proficiency Certificate
If you’re applying for a French?taught program, a DELF B2 or TCF level?4 (CEFR B2) certificate is required unless you've completed your studies in France or in French. For any English?taught courses, you may need IELTS or TOEFL at C1 level depending on the course
3. Passport or National ID Copy
A clear, valid copy of your passport or national identification is required to verify your identity when applying and for administrative registration after acceptance. International students generally upload this during application.
4. Motivation Letter (Lettre de Motivation)
Although not always mandatory for L1 entry, a motivation letter can strengthen your application— explaining why you chose the program, your goals, and any relevant experience. It’s especially useful if applying via e?candidat or Campus?France.
5. Curriculum Vitae (CV)
A CV highlighting your academic background, extracurriculars, projects, internships or language skills is recommended—particularly important if you aim to enter selective programs or show motivation beyond grades
6. Campus France / Parcoursup Application Confirmation
Depending on your nationality and origin of your diploma:
EU/EEA/Swiss applicants use Parcoursup from mid?January to March.
Non?EU applicants, often via Campus?France (CEF), submit a DAP dossier (October–December) and upload acceptance on e?candidat. This officially logs your admission pathway
Know more
Through its dynamic research clusters, interdisciplinary collaborations, and innovation policies, Lyon 1 secured a place within the top 50 global universities for innovation in a Reuters ranking. This achievement underscores how the university doesn’t just publish; it builds value, incubates projects, and converts scientific insight into societal solutions. Strong patent filings, EU projects, and spin-off support reinforce that positioning
By 2024, Lyon 1 held a QS global ranking around #601–650, climbing into #=562 in 2025 and projected at #=587 in 2026. Additionally, it ranks 2nd in France and top in the Auvergne–Rhône‑Alpes region according to EduRank criteria. These rankings reflect steady improvement in academic reputation, citations, and research metric performance—solid markers of sustained excellence over time
In 2022, UCBL researchers published over 7,523 scientific articles, covering an enormous range of disciplines from physics and chemistry to health and earth sciences. Maintaining this volume year after year illustrates both excellent output and sustained research capacity. With nearly 2,840 researchers and 78 labs and federations, the university produces at scale while preserving quality. Such output places Lyon 1 among top national and European performers in research volume and influence
In June 2023 UCBL and partner institutions filed a patent (published May 2024) on the therapeutic use of FUBP1 inhibitors for treating chronic hepatitis B infection. The invention targets viral cccDNA using antisense oligonucleotides like siRNA/shRNA to destabilize the template required for persistence. It represents a novel antiviral strategy with potential clinical impact. The work flows from UCBL’s strong biotech and molecular biology research environment, demonstrating its ability to translate molecular mechanisms into potential therapies against persistent viral infections.
Filed July 2022 and published September 2024, UCBL co-invented a diagnostic kit to detect replicating respiratory viruses by measuring interferon-stimulated gene transcripts from patient nasal or oral samples. This molecular method enables early infection detection before symptoms emerge. The associated kit offers a practical tool for monitoring outbreaks or clinical diagnostics. It draws on UCBL’s expertise in virology, immunology, and translational research, reflecting a commitment to emergent public health needs, particularly relevant in context of pandemics and respiratory disease surveillance.
A computer‑implemented method filed May 2022 and published July 2024 allows calculation of shear elasticity modulus of flexible tubes (e.g., blood vessels or implants) using image‑based deformation tracking. By analyzing spatiotemporal deformation and wave propagation through vessel walls, it estimates risk of rupture or compatibility. This innovation blends biomechanics, medical imaging, and software analytics. It serves cardiovascular research and implant design by quantifying material properties, reflecting UCBL’s biotech-engineering crossover research.
Embark on your educational journey with confidence! Our team of admission experts is here to guide you through the process. Book a free session now to receive personalized advice, assistance with applications, and insights into your dream school. Whether you're applying to college, graduate school, or specialized programs, we're here to help you succeed.
